Page last updated: 2024-10-31

mianserin and Opioid-Related Disorders

mianserin has been researched along with Opioid-Related Disorders in 3 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Opioid-Related Disorders: Disorders related to or resulting from abuse or misuse of OPIOIDS.

Research Excerpts

ExcerptRelevanceReference
"Mianserin (or placebo) was added to the routine medication protocol, during the 3-week in-patient phase of detoxification in a prospective, randomized, double blind, placebo controlled study."2.71The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study. ( Bar-Hamburger, R; Herman, I; Pick, CG; Schreiber, S; Shamir, D, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zullino, DF2
Krenz, S2
Favrat, B1
Zimmermann, G1
Bertschy, G1
Besson, J1
Herman, I1
Shamir, D1
Bar-Hamburger, R1
Pick, CG1
Schreiber, S1
Zimmerman, G1
Miozzari, A1
Rajeswaran, R1
Kolly, S1
Khazaal, Y1

Trials

2 trials available for mianserin and Opioid-Related Disorders

ArticleYear
The efficiency of a carbamazepine-mianserin combination scheme in opiate detoxification.
    Human psychopharmacology, 2004, Volume: 19, Issue:6

    Topics: Adult; Analgesics, Non-Narcotic; Antidepressive Agents, Second-Generation; Carbamazepine; Drug Evalu

2004
The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Addictive behaviors, 2005, Volume: 30, Issue:6

    Topics: Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Double

2005

Other Studies

1 other study available for mianserin and Opioid-Related Disorders

ArticleYear
Topiramate in opiate withdrawal- comparison with clonidine and with carbamazepine/mianserin.
    Substance abuse, 2004, Volume: 25, Issue:4

    Topics: Adrenergic alpha-Agonists; Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Carbama

2004